Insights On Outsourced Drug Development

  1. Overcoming Challenges To High-Concentration Formulation Development 3/25/2025

    Explore how the S-HiCon™ platform optimizes high-concentration therapeutic antibody formulations, overcoming stability and manufacturability challenges to deliver safe, effective therapies.

  2. Column Selection For RPLC-UV Impurity Analysis 7/17/2025

    Explore the performance of four column chemistries for RPLC-UV impurity analysis of liraglutide and semaglutide, which offers practical guidance for method development in peptide-based therapeutics.

  3. Assuring Multipotency Of Human Mesenchymal Stem Cells (hMSCs) 4/4/2025

    Stem cell research has revolutionized tissue repair and regenerative medicine. Discover how mesenchymal stem cells play a key role and offer insights into connective tissue repair, immune response, and inflammatory diseases.

  4. Advancing 3D Cell Culture Models For Clinical Relevance 4/9/2024

    Concerns about in vitro relevance and animal study limits have advanced cell culture tech. Explore how Organ-Chips offer a refined approach to studying human physiology.

  5. Advancements In Process And Payload Development 2/29/2024

    Continuous advancements in the process and payload development of ADCs and next-generation bioconjugates have the potential to progress targeted therapeutics and improve patient treatment options.

  6. Simplify Your Cell Culture Processes 11/13/2025

    Discover bioreactors that combine fast setup, robust design, and scalable performance to streamline cell culture workflows, which help you move from uncertainty to control, no matter your molecule.

  7. Target Product Profiles And Phase 1 Clinical Plans: Laying The Groundwork For Success 2/26/2025

    By integrating scientific rigor, regulatory foresight, and market awareness into early-stage planning, companies can leverage a robust TPP to optimize decision-making and development.

  8. Application Of LC-UV/MS Workflows To Increase Efficiency 7/29/2025

    Discover how LC-UV/MS workflows help overcome analytical challenges in GLP-1 analog development to streamline impurity identification and boost lab efficiency in research.

  9. AI-Enabled Phenotypic Analysis Of Label-Free Intestinal Organoids 3/10/2025

    Discover how advanced 3D models and AI-enabled imaging techniques revolutionize organoid research, which provides accurate phenotypic analysis to monitor growth and development in various organoid types.

  10. 5 Trends Impacting CMOs In 2025 2/4/2025

    In 2025, CMOs will navigate Annex 1 compliance, the BioSecure Act’s uncertainty, AI-driven drug development, supply chain challenges from tariffs, and pandemic preparedness strategies.